Sam Jacobo was born in El Paso, Texas and grew up in Riverside, California. He obtained his B.S. from Stanford University where he worked under Dr. Malhotra at Stanford School of Medicine. There, he helped develop chalcone derivatives to act as Keap1 agonists.
During his summers, he worked at Revolution Medicines where he helped synthesize rapamycin derivatives to act as selective mTORC1 allosteric inhibitors. Afterwards, he completed his M.S. from the University of San Francisco under Dr. Herman Nikolayevskiy. During his time there, he focused on synthesized DNA-alkylators.
As the latest addition to the Brown group, he plans to work on metal-catalyzed alkene difunctionalization.
In his spare time, he likes to search for old chemistry textbooks, visit cafes, run long distances, and binge indie films.
“So, if you say you take an ordinary person who is willing to devote a great deal of time and study and work and thinking and mathematics and time, then he has become a scientist.” – Richard Feynman